Back to the Future: The Role of Metabolic Studies in Therapeutic Advances.
作者信息
Milliner Dawn S, Lieske John C
机构信息
Divison of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
Division of Pediatric Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
出版信息
J Am Soc Nephrol. 2021 Dec 1;32(12):2980-2982. doi: 10.1681/ASN.2021101325.
Abstract
摘要
相似文献
1
Back to the Future: The Role of Metabolic Studies in Therapeutic Advances.《回到未来：代谢研究在治疗进展中的作用》
J Am Soc Nephrol. 2021 Dec 1;32(12):2980-2982. doi: 10.1681/ASN.2021101325.
2
Regenerative Techniques for Neuraxial Back Pain: a Systematic Review.用于脊柱源性背痛的再生技术：系统评价。
Curr Pain Headache Rep. 2019 Mar 11;23(3):20. doi: 10.1007/s11916-019-0758-0.
3
Historical Review of Studies on Sacroiliac Fatty Nodules (Recently Termed "Back Mice") as a Potential Cause of Low Back Pain.骶髂脂肪结节（最近称为“背部脂肪瘤”）作为下腰痛潜在病因的研究历史回顾。
Pain Ther. 2021 Dec;10(2):1029-1050. doi: 10.1007/s40122-021-00321-5. Epub 2021 Sep 16.
4
Evaluation of metabolic syndrome in patients with chronic low back pain: using the fourth Korea national health and nutrition examination survey data.慢性下腰痛患者代谢综合征的评估：利用韩国第四次全国健康与营养检查调查数据
Chonnam Med J. 2011 Dec;47(3):160-4. doi: 10.4068/cmj.2011.47.3.160. Epub 2011 Dec 26.
5
Neurostimulation for the treatment of axial back pain: a review of mechanisms, techniques, outcomes, and future advances.神经刺激治疗轴性背痛：机制、技术、疗效及未来进展综述
Neuromodulation. 2014 Oct;17 Suppl 2:52-68. doi: 10.1111/j.1525-1403.2012.00530.x.
6
[Advances in cooperativity and mechanism of combination of Back-shu and Front-mu points].[背俞穴与募穴配伍协同作用及机制研究进展]
Zhongguo Zhen Jiu. 2011 Sep;31(9):862-4.
7
The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain.退变椎间盘与椎间盘源性背痛的细胞病理生物学
Rheumatology (Oxford). 2009 Jan;48(1):5-10. doi: 10.1093/rheumatology/ken396. Epub 2008 Oct 14.
8
Evaluation of metabolic syndrome in patients with chronic low back pain.评估慢性腰痛患者的代谢综合征。
Rheumatol Int. 2012 Mar;32(3):663-7. doi: 10.1007/s00296-010-1693-x. Epub 2010 Dec 5.
9
Epigenetic manifestation of metabolic syndrome and dietary management.代谢综合征的表观遗传表现与饮食管理。
Antioxid Redox Signal. 2012 Jul 15;17(2):254-81. doi: 10.1089/ars.2011.4387. Epub 2012 Mar 2.
10
Causal mechanisms in the clinical course and treatment of back pain.腰痛临床病程和治疗中的因果机制。
Best Pract Res Clin Rheumatol. 2016 Dec;30(6):1074-1083. doi: 10.1016/j.berh.2017.04.001. Epub 2017 May 5.
本文引用的文献
1
Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients.1 型原发性高草酸尿症患者内源性草酸盐的产生。
J Am Soc Nephrol. 2021 Dec 1;32(12):3175-3186. doi: 10.1681/ASN.2021060729.
2
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.卢马昔兰，用于 1 型原发性高草酸尿症的 RNAi 疗法。
N Engl J Med. 2021 Apr 1;384(13):1216-1226. doi: 10.1056/NEJMoa2021712.
3
Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias.基于小分子的酶抑制剂在原发性高草酸尿症治疗中的应用
J Pers Med. 2021 Jan 27;11(2):74. doi: 10.3390/jpm11020074.
4
Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity.通过 RNA 干扰抑制肝乳酸脱氢酶活性减少原发性高草酸尿症小鼠模型中的尿草酸盐排泄。
Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2203-2209. doi: 10.1016/j.bbadis.2019.04.017. Epub 2019 May 2.
5
Stiripentol protects against calcium oxalate nephrolithiasis and ethylene glycol poisoning.戊四醇可预防草酸钙肾结石和乙二醇中毒。
J Clin Invest. 2019 Apr 4;129(6):2571-2577. doi: 10.1172/JCI99822.
6
Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria.特异性抑制肝乳酸脱氢酶可减少原发性高草酸尿症小鼠模型中的草酸盐生成。
Mol Ther. 2018 Aug 1;26(8):1983-1995. doi: 10.1016/j.ymthe.2018.05.016. Epub 2018 Jun 15.
7
Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.原发性高草酸尿症中的羟脯氨酸代谢和草酸盐合成。
J Am Soc Nephrol. 2018 Jun;29(6):1615-1623. doi: 10.1681/ASN.2017040390. Epub 2018 Mar 27.
8
Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1.用Dicer底物小干扰RNA抑制乙醇酸氧化酶可减少1型原发性高草酸尿症小鼠模型中的草酸钙沉积。
Mol Ther. 2016 Apr;24(4):770-8. doi: 10.1038/mt.2016.4. Epub 2016 Jan 13.
9
Conversion of glycine to oxalate in a normal subject.正常受试者中甘氨酸向草酸盐的转化。
Lancet. 1959 Nov 14;2(7107):810. doi: 10.1016/s0140-6736(59)90752-4.
10
Clinical expression and long-term outcomes of primary hyperoxaluria types 1 and 2.1型和2型原发性高草酸尿症的临床表现及长期预后
J Nephrol. 1998 Mar-Apr;11 Suppl 1:56-9.
Zotero 插件